Skip to content

Sarcoma Coalition Programming

The Sarcoma Coalition hosts experts speaking on subjects critical to sarcoma patients in this series.

2025

https://youtu.be/1GWZejubPNo?si=BXiItqb8Pmjg_7kECurrent Status of Circulating Tumor DNA for Sarcomas – Discussion by a Panel of Experts including Brian Crompton, MD and  David Shulman, MD –  Dana Farber Cancer Institute, Maggie Zhou, MD – Stanford Health Care, Lawrence C. Park, PhD – Princess Margaret Cancer Center, Gabriel Tinoco, MF – James Cancer Center, Joanna Pryzbyl, PhD – McGill University, Montreal sponsored by NLMSF.

NCCS Cancer State of Survivorship thumbnail

State of Survivorship by the National Coalition for Cancer Survivorship: Current National Coalition for Cancer Survivorship perspectives on the State of Cancer Survivorship, and Legislative Updates to date in 2025. Advisory Panel Member, Veronika Panagiotous, PhD, discusses SURVIVORSHIP during and after cancer.

Should Hypofractionated Radiation be Adopted as Standard of Care for Extremity and Truncal Sarcomas – B. Ashleigh Guadagnolo, MD, MPH, FASTRO, Radiation Oncologist, at MD Anderson Cancer Center, discusses whether hypofractionated radiation should get adopted as standard of care for extremity and truncal sarcomas.

2024

What is the Sarculator and How does It Work – Discussion with Nam Bui, MD – Discussion with Nam Bui, MD, of the Stanford Cancer Center on what the Sarculator is and how it is used in the treatment of patients with sarcomas of the extremities and the retroperitoneum. Sponsored by NLMSF.

Immunotherapy in Sarcoma: Current Data/Promising Strategies – Christian Meyer, MD, PhD of the Johns Hopkins Cancer Institute Sarcoma Center – Discusses the American Society of Clinical Oncologists (ASCO) publication – Immunotherapy in Sarcoma: Current Data/Promising Strategies. Sponsored by NLMSF.

The Phase 1a/2 Clinical Trial using GI102 for Patients with Advanced Sarcoma – Dr, Vishu Avutu, MD, Sarcoma Medical Oncologist at Memorial Sloan Kettering Cancer Center discusses the Phase 1a/2 Clinical Trial of GI-102 for Patients with Advanced Sarcomas. Sponsored by NLMSF.

Nutrition and Cancer: Virtual Discussion with Alison Tierny Oncology Dietitian – Cancer Empowerment through Experience: The Journey of a Cancer Dietitian and Cancer Thriver Alison Tierney. Sponsored by NLMSF.

Clinical Trials Perspectives a Panel Discussion by Sarcoma Medical Oncologists

2023

Treatment- Related Cardiotoxicity: The Impact of Cancer Treatments on the Heart – Eileen Dimond, RN, MS, NIH Cardiotoxicity Task Force Member.

ctDNA panel 2023 Listen & Learn

Circulating Tumor DNA Status and Future Directions for Sarcoma – Panel included Dr. Nam Quoc Bui, Dr. Brian Compton, Dr. Elizabeth Davis, Dr. Erlinda Maria Gordon, Dr. Matthew Hemming, Dr. Elise Nasif, Dr. Joanna Pryzbyl, Dr. David Schulman and Dr. Jonathan Trent.